XML 50 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Related Party Transactions (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 01, 2017
shares
Feb. 10, 2017
shares
Feb. 02, 2017
shares
Jan. 10, 2017
shares
Sep. 09, 2016
USD ($)
$ / shares
shares
Feb. 02, 2016
USD ($)
$ / shares
shares
May 01, 2015
USD ($)
Installment
Feb. 28, 2017
shares
Feb. 23, 2017
USD ($)
Feb. 17, 2017
shares
Sep. 25, 2014
USD ($)
Number
Mar. 31, 2017
USD ($)
$ / shares
shares
Mar. 31, 2016
USD ($)
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
Mar. 15, 2016
shares
Nov. 01, 2015
USD ($)
Common stock shares reserved under stock option plan | shares                       19,595,000   19,595,000      
Accounts payable                       $ 76,598   $ 33,290 $ 30,095    
Research and development expense                       $ 79,080 $ 111,822 $ 309,503 281,218    
Exercise Price | $ / shares                       $ 1.62   $ 1.42      
Charitable Gift Agreement [Member]                                  
Donation to the University                                 $ 83,000
Charitable Grant Agreement [Member]                                  
Donation to the University                     $ 75,000            
Donation periodic payment                     $ 9,375            
Number of installments | Number                     8            
KCC [Member] | Loan agreement [Member]                                  
Convertible debt financing, Maximum amount         $ 900,000                        
Convertible debt financing, Loan received         700,000       $ 395,000                
Convertible debt financing, Remaining amount         $ 200,000                        
Interest rate         7.00%       7.00%                
Maturity date         Dec. 31, 2017       Feb. 23, 2018                
Debt instrument conversion feature        

(i) $1.54, or the closing price of the Company’s common stock on the day prior to the issuance of the Note or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to convert the Note, subject to a floor price of $1.23

      (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.                
Debt instrument floor price | $ / shares         $ 1.23                        
KCC [Member] | Series B Warrant [Member]                                  
Common stock shares reserved under stock option plan | shares 1,326,087                                
Debt conversion converted instrument shares issued | shares 1,181,194         2,173,913                      
Exercise Price | $ / shares           $ 0.46                      
Proceeds from issuance of common stock           $ 1,000,000                      
KCC [Member] | Series E Warrant [Member] | Loan agreement [Member]                                  
Common stock shares reserved under stock option plan | shares         584,416                        
Debt instrument conversion feature        

(i) $1.54, the closing price of the Company’s common stock on the day prior to issuance of the Series E Warrant; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to exercise the Series E Warrant

                       
Warrant expiration period         5 years                        
KCC [Member] | Series F Warrant [Member] | Loan agreement [Member]                                  
Common stock shares reserved under stock option plan | shares               114,493                  
Debt instrument conversion feature               (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.                  
Warrant expiration period               5 years                  
KCC [Member] | Series B and C warrants [Member]                                  
Debt conversion converted instrument shares issued | shares 4,273,831                                
KCC [Member] | Series C Warrant [Member]                                  
Common stock shares reserved under stock option plan | shares 3,500,000                                
Debt conversion converted instrument shares issued | shares 3,092,637                                
StemCell Systems [Member]                                  
Incurred expenses                       $ 54,000 74,567 $ 184,517 194,336    
Satterlee Stephens LLP [Member]                                  
Accounts payable                           11,750      
Joseph Sierchio [Member] | Stock option [Member]                                  
Common stock shares reserved under stock option plan | shares   70,000                              
Debt conversion converted instrument shares issued | shares   38,642                              
Joseph Sierchio [Member] | Loan agreement [Member]                                  
Convertible debt financing, Loan received                 $ 25,000                
Interest rate                 7.00%                
Maturity date                 Feb. 23, 2018                
Debt instrument conversion feature                 (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.                
Joseph Sierchio [Member] | Series F Warrant [Member] | Loan agreement [Member]                                  
Common stock shares reserved under stock option plan | shares               7,246                  
Debt instrument conversion feature               (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.                  
Warrant expiration period               5 years                  
Kenneth Kirkland [Member] | Stock option [Member]                                  
Common stock shares reserved under stock option plan | shares     40,000                            
Debt conversion converted instrument shares issued | shares     29,642                            
Thomas bold [Member] | Stock option [Member]                                  
Common stock shares reserved under stock option plan | shares                   40,000              
Debt conversion converted instrument shares issued | shares                   34,296              
Dr. Gerlach [Member]                                  
Accounts payable                       10,080   18,540      
Compensation expense for services                       10,080   42,480 36,720    
Dr. Gerlach [Member] | Option agreement [Member]                                  
Number of installments | Installment             4                    
Fees payable under agreement             $ 24,000                    
Due to related party periodic payment             6,000                    
Research and development expense             $ 24,000                    
Dr. Gerlach [Member] | Series A [Member]                                  
Common stock shares reserved under stock option plan | shares       240,000                          
Debt conversion converted instrument shares issued | shares       204,571                          
Joseph Sierchio [Member]                                  
Annual retainer payable                       $ 6,000   $ 6,000      
Common stock shares reserved under stock option plan | shares                           50,000   50,000  
Exercise price | $ / shares                       $ 1.91   $ 1.91      
Legal fees                       $ 103,151 $ 36,850 $ 168,775 101,700    
Accounts payable                       66,518   11,750 $ 8,322    
Kenneth Kirkland [Member]                                  
Annual retainer payable                       $ 6,000   $ 6,000      
Common stock shares reserved under stock option plan | shares                           50,000   50,000  
Exercise price | $ / shares                       $ 1.91   $ 1.91